GHS GREENVILLE MEMORIAL HOSPITAL
- Type
- Teaching hospital
- Where
- GREENVILLE, SC
- Medicare CCN
- 420078
- Received
- $911,346 in 300 records, 2019 ($216,049 general, $695,297 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2019 | General payment | 26 | $216,049 |
| 2019 | Research payment | 274 | $695,297 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Gilead Sciences, Inc. | 33 | $310,529 | 2019 |
| Intercept Pharmaceuticals, Inc. | 19 | $262,362 | 2019 |
| PFIZER INC. | 11 | $108,063 | 2019 |
| Aptevo Therapeutics Inc | 5 | $62,692 | 2019 |
| Medical Device Business Services, Inc. | 8 | $35,196 | 2019 |
| MDD US Operations, LLC | 174 | $31,944 | 2019 |
| CSL Behring | 5 | $23,350 | 2019 |
| Merck Sharp & Dohme LLC | 7 | $14,696 | 2019 |
| Boston Scientific Corporation | 8 | $11,357 | 2019 |
| Zimmer Biomet Holdings, Inc. | 3 | $10,028 | 2019 |
| Janssen Research & Development, LLC | 1 | $9,450 | 2019 |
| GenMark Diagnostics, Inc. | 1 | $7,159 | 2019 |
| Medline Industries LP | 3 | $4,500 | 2019 |
| JAZZ PHARMACEUTICALS INC. | 4 | $4,283 | 2019 |
| Stryker Corporation | 2 | $3,500 | 2019 |
| Genentech, Inc. | 3 | $2,557 | 2019 |
| MicroVention, Inc. | 1 | $2,500 | 2019 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $2,250 | 2019 |
| Amarin Pharma, Inc. | 1 | $1,500 | 2019 |
| Penumbra, Inc. | 1 | $1,500 | 2019 |
| BIOTRONIK INC. | 3 | $1,109 | 2019 |
| Allergan, Inc. | 1 | $750 | 2019 |
| Hollister Incorporated | 1 | $31 | 2019 |
| Saol Therapeutics Inc. | 1 | $30 | 2019 |
| Becton, Dickinson and Company | 1 | $4 | 2019 |
| Astellas Pharma Global Development | 1 | $2 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 274 | $695,297 |
| Grant | 5 | $184,046 |
| Space rental or facility fees (teaching hospital only) | 11 | $18,000 |
| Honoraria | 1 | $7,159 |
| Charitable Contribution | 3 | $4,500 |
| Education | 3 | $2,254 |
| Gift | 2 | $58 |
| Food and Beverage | 1 | $31 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | Gilead Sciences, Inc. | $171,796 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-12-31 | Zimmer Biomet Holdings, Inc. | $28 | Gift | In-kind items and services | Zimmer Biomet Instruments and Implants Device, General | 2019 | |
| 2019-12-26 | Medical Device Business Services, Inc. | $16,196 | Research payment | Cash or cash equivalent | Visitag Device, Cardiology | Evaluation of Visitag Surpoint Module with External Processing Unit when used with the Thermocool Smarttouch SF and Ther | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $454 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $454 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-25 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-12-16 | Boston Scientific Corporation | $4,491 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | RANGER II SFA | 2019 |
| 2019-12-10 | PFIZER INC. | $5,149 | Research payment | Cash or cash equivalent | BAVENCIO Drug, ONCOLOGY | A RANDOMIZED DOUBLEBLIND PHASE 3 STUDY OF AVELUMAB IN COMBINATION WITH STANDARD OF CARE CHEMORADIOTHERAPY CISPLATIN PLUS | 2019 |
| 2019-12-10 | PFIZER INC. | $747 | Research payment | Cash or cash equivalent | BAVENCIO Drug, ONCOLOGY | A RANDOMIZED DOUBLEBLIND PHASE 3 STUDY OF AVELUMAB IN COMBINATION WITH STANDARD OF CARE CHEMORADIOTHERAPY CISPLATIN PLUS | 2019 |
| 2019-12-05 | CSL Behring | $16,500 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-12-05 | CSL Behring | $1,850 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-12-05 | CSL Behring | $1,500 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-12-05 | CSL Behring | $1,000 | Research payment | Cash or cash equivalent | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 | |
| 2019-11-30 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $454 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $454 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $454 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $422 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $262 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $51 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-30 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-11-25 | Intercept Pharmaceuticals, Inc. | $4,965 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1011866 | 2019 |
| 2019-11-25 | Merck Sharp & Dohme LLC | $639 | Research payment | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | Phase 1,2 Study Of Intratumoral G100 With Or Without Anti-PD-1 Antibody Therapy In Patients With Follicular Non-Hodgkin | 2019 |
| 2019-11-13 | PFIZER INC. | $461 | Research payment | Cash or cash equivalent | BAVENCIO Drug, ONCOLOGY | A RANDOMIZED DOUBLEBLIND PHASE 3 STUDY OF AVELUMAB IN COMBINATION WITH STANDARD OF CARE CHEMORADIOTHERAPY CISPLATIN PLUS | 2019 |
| 2019-10-31 | Medical Device Business Services, Inc. | $11,000 | Research payment | Cash or cash equivalent | Visitag Device, Cardiology | Evaluation of Visitag Surpoint Module with External Processing Unit when used with the Thermocool Smarttouch SF and Ther | 2019 |
| 2019-10-31 | Janssen Research & Development, LLC | $9,450 | Research payment | Cash or cash equivalent | A Randomized Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Patients with | 2019 | |
| 2019-10-30 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $384 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $262 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $51 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $51 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $51 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-30 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-29 | BIOTRONIK INC. | $500 | Research payment | Cash or cash equivalent | Orsiro Device, Cardiology/Vascular Diseases | BIOFLOW-V | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $416 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $384 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $384 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $384 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $262 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $262 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $262 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $51 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $44 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-18 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-10-17 | Intercept Pharmaceuticals, Inc. | $11,811 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1011866 | 2019 |
| 2019-10-15 | Merck Sharp & Dohme LLC | $956 | Research payment | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | A Phase III Randomized, Controlled Clinical Trial of Pembrolizumab with or without Platinum-Based Combination Chemothera | 2019 |
| 2019-10-11 | Penumbra, Inc. | $1,500 | Education | Cash or cash equivalent | 2019 | ||
| 2019-10-10 | Intercept Pharmaceuticals, Inc. | $5,750 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1011866 | 2019 |
| 2019-10-03 | Medline Industries LP | $1,000 | Charitable Contribution | Cash or cash equivalent | 2019 | ||
| 2019-10-02 | Gilead Sciences, Inc. | $1,965 | Research payment | Cash or cash equivalent | A Phase 2, Randomized, Double-blind, Placebo-Controlled Study evaluating the safety and efficacy of Selonsertib, GS-0976 | 2019 | |
| 2019-09-19 | Intercept Pharmaceuticals, Inc. | $18,447 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1011866 | 2019 |
| 2019-09-18 | Gilead Sciences, Inc. | $4,180 | Research payment | Cash or cash equivalent | A Phase 2, Randomized, Double-blind, Placebo-Controlled Study evaluating the safety and efficacy of Selonsertib, GS-0976 | 2019 | |
| 2019-09-18 | Gilead Sciences, Inc. | $2,816 | Research payment | Cash or cash equivalent | STELLAR-3 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonserti | 2019 | |
| 2019-09-18 | Medline Industries LP | $2,500 | Charitable Contribution | Cash or cash equivalent | 2019 | ||
| 2019-09-12 | Medline Industries LP | $1,000 | Charitable Contribution | Cash or cash equivalent | 2019 | ||
| 2019-09-10 | CSL Behring | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-08-29 | MicroVention, Inc. | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2019 | ||
| 2019-08-28 | Gilead Sciences, Inc. | $2,031 | Research payment | Cash or cash equivalent | A Phase 2, Randomized, Double-blind, Placebo-Controlled Study evaluating the safety and efficacy of Selonsertib, GS-0976 | 2019 | |
| 2019-08-27 | Intercept Pharmaceuticals, Inc. | $13,212 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1011866 | 2019 |
| 2019-08-27 | Intercept Pharmaceuticals, Inc. | $923 | Research payment | Cash or cash equivalent | OCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY | 1011866 | 2019 |
| 2019-08-26 | Merck Sharp & Dohme LLC | $10,544 | Research payment | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | Phase 1,2 Study Of Intratumoral G100 With Or Without Anti-PD-1 Antibody Therapy In Patients With Follicular Non-Hodgkin | 2019 |
| 2019-08-26 | Gilead Sciences, Inc. | $10,065 | Research payment | Cash or cash equivalent | A Phase 2, Randomized, Double-blind, Placebo-Controlled Study evaluating the safety and efficacy of Selonsertib, GS-0976 | 2019 | |
| 2019-08-23 | Becton, Dickinson and Company | $4 | Education | In-kind items and services | 2019 | ||
| 2019-08-22 | PFIZER INC. | $12,278 | Research payment | Cash or cash equivalent | BAVENCIO Drug, ONCOLOGY | A RANDOMIZED DOUBLEBLIND PHASE 3 STUDY OF AVELUMAB IN COMBINATION WITH STANDARD OF CARE CHEMORADIOTHERAPY CISPLATIN PLUS | 2019 |
| 2019-08-22 | Stryker Corporation | $1,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | TREVO Device, MICROCATHETERSTENTRIEVER | 2019 | |
| 2019-08-21 | Gilead Sciences, Inc. | $3,473 | Research payment | Cash or cash equivalent | A Phase 2, Randomized, Double-blind, Placebo-Controlled Study evaluating the safety and efficacy of Selonsertib, GS-0976 | 2019 | |
| 2019-08-21 | Gilead Sciences, Inc. | $2,076 | Research payment | Cash or cash equivalent | STELLAR-3 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonserti | 2019 | |
| 2019-08-21 | Gilead Sciences, Inc. | $1,164 | Research payment | Cash or cash equivalent | STELLAR-3 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonserti | 2019 | |
| 2019-08-20 | MDD US Operations, LLC | $454 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-20 | MDD US Operations, LLC | $454 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-20 | MDD US Operations, LLC | $454 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-20 | MDD US Operations, LLC | $384 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-20 | MDD US Operations, LLC | $262 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-20 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-20 | MDD US Operations, LLC | $51 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-20 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-20 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-20 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-20 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-20 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-20 | MDD US Operations, LLC | $38 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-20 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-20 | MDD US Operations, LLC | $32 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-08-19 | Gilead Sciences, Inc. | $150 | Research payment | Cash or cash equivalent | STELLAR-3 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonserti | 2019 | |
| 2019-08-15 | Merck Sharp & Dohme LLC | $105 | Research payment | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | A Phase III Randomized, Controlled Clinical Trial of Pembrolizumab with or without Platinum-Based Combination Chemothera | 2019 |
| 2019-08-08 | Stryker Corporation | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 1688 HD 3 CHIP CAMERA Device, VISUALIZATION | 2019 | |
| 2019-08-07 | Gilead Sciences, Inc. | $3,740 | Research payment | Cash or cash equivalent | STELLAR-3 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonserti | 2019 | |
| 2019-08-07 | Astellas Pharma Global Development | $2 | Research payment | In-kind items and services | XOSPATA Drug, ONCOLOGY | A Phase 3 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of the FLT3 Inhibitor Gilteritinib ASP2215 Ad | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $5,000 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $518 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $454 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $422 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $422 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $422 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $422 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $262 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $262 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $262 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $262 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $96 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $51 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $51 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
| 2019-07-31 | MDD US Operations, LLC | $51 | Research payment | Cash or cash equivalent | Xadago Drug, Neurology | Xadago Pro-Go | 2019 |
The latest 200 records of 300.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Greenville, SC, county Greenville County, SC, state South Carolina; placed by its city name.
| Measure | Place (city or town) Greenville, SC | County Greenville County, SC | State South Carolina |
|---|---|---|---|
| Population B01003 | 72,935 | 548,166 | 5,296,225 |
| Population, 2020 census P1 | 70,720 | 525,534 | 5,118,425 |
| Median age B01002 | 34.7 | 38.4 | 40.2 |
| Under 18 B01001 | 17.2% | 22.9% | 21.4% |
| 65 and over B01001 | 15.1% | 16.7% | 18.9% |
| Households B11001 | 35,482 | 220,565 | 2,117,989 |
| Foreign born B05002 | 7.3% | 8.7% | 5.8% |
| Median household income B19013 | $71,472 | $76,932 | $69,324 |
| Median family income B19113 | $114,230 | $96,425 | $86,707 |
| Per capita income B19301 | $58,929 | $43,319 | $39,236 |
| Poverty rate B17001 | 14.0% | 10.8% | 14.1% |
| Unemployment rate B23025 | 4.4% | 4.4% | 4.9% |
| Civilian labor force B23025 | 42,471 | 285,521 | 2,560,429 |
| Mean commute (minutes) B08013 | 19.0 | 23.4 | 25.6 |
| Bachelor's degree or higher B15003 | 55.5% | 41.3% | 32.1% |
| Housing units B25001 | 39,373 | 238,260 | 2,443,039 |
| Owner-occupied B25003 | 41.1% | 68.9% | 71.9% |
| Renters B25003 | 58.9% | 31.1% | 28.1% |
| Median home value B25077 | $487,500 | $299,000 | $259,000 |
| Median gross rent B25064 | $1,312 | $1,262 | $1,180 |
| White, not Hispanic B03002 | 66.2% | 65.2% | 61.9% |
| Black B03002 | 19.4% | 15.3% | 24.6% |
| Hispanic or Latino B03002 | 7.2% | 11.6% | 7.4% |
| Asian B03002 | 2.2% | 2.5% | 1.7% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Greenville, SC.
Comments